Mediforum, a leading dementia and Alzheimer’s treatment R&D company, was chosen by the city of Gunpo’s Dementia Relief Center as a partner in developing treatments and providing relief to individuals suffering from Alzheimer’s dementia.

LOS ANGELES, CA, January 13, 2022 /24-7PressRelease/ — Mediforum, a leading dementia and Alzheimer’s treatment research and development company, was chosen by the city of Gunpo’s Dementia Relief Center as a designated partner in developing treatment options and providing relief to individuals suffering from Alzheimer’s dementia and their extended families.

The organization works with partner entities to provide social and cultural services and a sense of community to improve the environment in overcoming dementia. The relief center works at a grassroots level to improve negative perceptions of dementia and helps foster an environment in which dementia patients and their families can live in harmony with the rest of the community. Alzheimer’s and dementia patients and their respective families are educated and kept up-to-date on the best practices and habits for dealing with Alzheimer’s and dementia patients, including but not limited to dietary practices, daily routines, personal hygiene and mobility issues, in essence, providing the foundations for a support group on a city-wide level.

In addition to the educational aspects of the services, Mediforum’s Myungminwon traditional Korean medicine and BrainOne supplements were also introduced to the center to help treat and reverse Alzheimer’s dementia in the patients. It is part of a multi-prong approach by the center to provide therapy and the best quality of life for patients suffering from Alzheimer’s and dementia within the city. Gunpo city is notable as an advanced, high-tech yet cultural city providing quality social services and programs.

Mediforum is a bio-tech firm out of Seoul, Korea that is leading the race to find a treatment for Alzheimer’s dementia with a focus on producing safe and effective drugs and supplements without the harmful side-effects common in drugs today. The company is the first to reach the 3rd phase clinical trial in Korea for the treatment of Alzheimer’s dementia.

Myungmin is available in four different formulations with varying strengths and forms for ease of consumption.

Myungminhwan is a specially formulated herbal supplement that is prepared in another traditional form of small bead-size chewable balls.

Myungmindan is prepared in a distinctly traditional way as to maximize the experience of its unique aroma and taste. The supplement is made in a marble-size chewable ball which allows for easy chewing and consumption.

Myungminwon is a liquid based herbal supplement that has the highest concentration of the active natural compounds that work to fight beta amyloid plaque, stimulate neurogenesis, improve overall brain health while also aiding in enhancing memory and concentration. The liquid form allows for easier consumption for individuals who suffer from dysphagia or have difficulty with swallowing.

Myungminwon Gold is the most premium formulation in the Myungmin Series. In addition to all the benefits of Myungminwon, it also includes cervi parvum comu extract which greatly boosts strength, endurance, and improves your immune system.

Mediforum has partnered with the Parkinson’s Disease Association in Korea and conducted studies showing improvements in quality of life for individuals suffering from Parkinson’s disease. Patients exhibited a positive improvement in tremor of the limbs, motor skills, an increased appetite and mental acuity.

Myungmin series was recently featured on RadioKorea as a treatment for multiple forms of dementia, Alzheimer’s and Parkinson’s disease.

Mediforum was born out of researchers working at leading universities in Korea in the field of medicine and traditional medicine. Their mission has been one of producing effective and safe supplements and drugs utilitizing naturally sourced compounds and testing them vigorously utilizing western clinical trial methodology. Having seen the long list of side-effects associated with the vast majority of intervention strategies for Alzheimer’s and cancer, Mediforum is leading the way to produce supplements and drugs to improve the quality of life for those suffering from such conditions. The company also offers a vast lineup of rapid PCR diagnostics test kits for HPV and STDs and other genetic biomarkers and conditions.

Related Links:

For the original version of this press release, please visit here